Clinical Study of the Therapeutic Efficacy and Safety of Emedastine Difumarate versus Terfenadine in the Treatment of Seasonal Allergic Rhinitis
暂无分享,去创建一个
[1] H. Eichler,et al. Pharmacokinetic and mass balance study of unlabelled and 14 C-labelled emedastine difumarate in healthy volunteers , 2002, Xenobiotica; the fate of foreign compounds in biological systems.
[2] U. Herranz,et al. Emedastine-ketoconazole: pharmacokinetic and pharmacodynamic interactions in healthy volunteers. , 2001, International journal of clinical pharmacology and therapeutics.
[3] B. Jansen,et al. Pharmacokinetics and pharmacodynamics of the novel H1-receptor antagonist emedastine in healthy volunteers , 2000, European Journal of Clinical Pharmacology.
[4] Steven J Smith,et al. Cardiovascular Toxicity of Antihistamines , 1994, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[5] K. Goa,et al. Terfenadine. An updated review of its pharmacological properties and therapeutic efficacy. , 1990, Drugs.
[6] K. Yokota,et al. General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate. 2nd communication: Effects on the circulation and the other systems. , 1988, Arzneimittel-Forschung.
[7] T. Saito,et al. General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate. 1st communication: effects on the central nervous system. , 1988, Arzneimittel-Forschung.
[8] G. Tsukamoto,et al. Effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimida zole difumarate (KB-2413), a new antiallergic, on chemical mediators. , 1984, Arzneimittel-Forschung.
[9] T. Saito,et al. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413). , 1984, Arzneimittel-Forschung.
[10] J. K. Woodward,et al. Terfenadine, the first non-sedating antihistamine. , 1982, Arzneimittel-Forschung.
[11] L. L. Henderson. Allergic Diseases: Diagnosis and Management , 1973 .